Cigna Investments Inc. New raised its position in UnitedHealth Group Inc (NYSE:UNH) by 30.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 33,688 shares of the healthcare conglomerate’s stock after purchasing an additional 7,797 shares during the quarter. UnitedHealth Group comprises approximately 1.1% of Cigna Investments Inc. New’s investment portfolio, making the stock its 11th biggest holding. Cigna Investments Inc. New’s holdings in UnitedHealth Group were worth $8,400,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Country Trust Bank increased its stake in shares of UnitedHealth Group by 556.3% in the first quarter. Country Trust Bank now owns 105 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 89 shares during the period. Tobias Financial Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $29,000. RMR Wealth Builders acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $29,000. HBC Financial Services PLLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Lion Street Advisors LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $31,000. Institutional investors own 87.10% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $228.39, for a total value of $2,283,900.00. Following the completion of the sale, the director now owns 158,598 shares in the company, valued at approximately $36,222,197.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stephen J. Hemsley sold 45,637 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the completion of the sale, the director now owns 1,013,122 shares of the company’s stock, valued at approximately $292,903,701.42. The disclosure for this sale can be found here. In the last quarter, insiders sold 65,637 shares of company stock valued at $17,723,013. Insiders own 0.80% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.63 by $0.09. The business had revenue of $64.40 billion during the quarter, compared to the consensus estimate of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.73 EPS. On average, equities research analysts predict that UnitedHealth Group Inc will post 16.24 EPS for the current fiscal year.
UNH has been the topic of several analyst reports. Citigroup dropped their price target on shares of UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $289.00 to $371.00 and gave the company an “overweight” rating in a report on Thursday, April 30th. Stephens increased their price objective on shares of UnitedHealth Group from $300.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, April 15th. Credit Suisse Group decreased their price objective on shares of UnitedHealth Group from $330.00 to $325.00 and set an “outperform” rating for the company in a report on Thursday, April 16th. Finally, Barclays reiterated a “buy” rating and issued a $322.00 price objective on shares of UnitedHealth Group in a report on Sunday, March 29th. Four analysts have rated the stock with a hold rating and twenty have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $319.68.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.